Patents by Inventor Moataz M. Gadalla

Moataz M. Gadalla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treatment of sleep-related breathing disorders
    Patent number: 10688096
    Abstract: Described herein are methods for modulation of the activity of the carotid body that afford therapeutic benefit for sleep-related breathing disorders and related conditions.
    Type: Grant
    Filed: April 11, 2011
    Date of Patent: June 23, 2020
    Assignees: The University of Chicago, The Johns Hopkins University
    Inventors: Solomon H. Snyder, Moataz M. Gadalla, Nanduri R. Prabhakar, Gregory Stein, Gary Pace
  • Inhibition of beta-amyloid peptide aggregation
    Patent number: 9233106
    Abstract: The present invention relates to methods of using cocaine-binding-site ligands and cocaine-binding-site RNA aptamers to treat or prevent Alzheimer's Disease and to reduce or prevent aggregation of beta-amyloid peptides in a subject.
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: January 12, 2016
    Assignee: CORNELL RESEARCH FOUNDATION, INC.
    Inventors: George P. Hess, Moataz M. Gadalla
  • METHODS FOR TREATMENT OF SLEEP-RELATED BREATHING DISORDERS
    Publication number: 20130131028
    Abstract: Described herein are methods for modulation of the activity of the carotid body that afford therapeutic benefit for sleep-related breathing disorders and related conditions.
    Type: Application
    Filed: April 11, 2011
    Publication date: May 23, 2013
    Applicants: JOHNS HOPKINS UNIVERSITY, SOVA PHARMACEUTICALS, INC., THE UNIVERSITY OF CHICAGO
    Inventors: Solomon H. Snyder, Moataz M. Gadalla, Nanduri R. Prabhakar, Gregory Stein, Gary Pace
  • INHIBITION OF BETA-AMYLOID PEPTIDE AGGREGATION
    Publication number: 20100069468
    Abstract: The present invention relates to methods of using cocaine-binding-site ligands and cocaine-binding-site RNA aptamers to treat or prevent Alzheimer's Disease and to reduce or prevent aggregation of beta-amyloid peptides in a subject.
    Type: Application
    Filed: July 12, 2007
    Publication date: March 18, 2010
    Applicant: CORNELL RESEARCH FOUNDATION, INC.
    Inventors: George P. Hess, Moataz M. Gadalla